Filing Details
- Accession Number:
- 0001246360-14-001858
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-19 11:21:09
- Reporting Period:
- 2014-03-17
- Filing Date:
- 2014-03-19
- Accepted Time:
- 2014-03-19 11:21:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1066026 | Concur Technologies Inc | CNQR | Services-Prepackaged Software (7372) | 911608052 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219071 | Rajeev Singh | 601 108Th Avenue Ne Suite 1000 Bellevue WA 98004 | Coo + President | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-03-17 | 15,000 | $0.00 | 155,884 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-03-17 | 15,000 | $106.62 | 140,884 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2014-03-17 | 15,000 | $0.00 | 15,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-03-15 | No | 4 | M | Direct |
Footnotes
- Restricted Stock Units - no purchase price for this transaction.
- Restricted Stock Units - no exercise price for this transaction.
- The restricted stock units shall vest 25% on each of the first four anniversaries of the date of grant.
- Not applicable.
- The transaction indicated was conducted under an approved 10b5-1 Plan. The price indicated is the weighted average sale price for the shares sold. The individual sale prices for the shares indicated range from $105.52 to $107.35.